| Name | Title | Contact Details |
|---|
Founded in 1986 in Queens, New York, Sabra Dipping Company is a leader in the refrigerated dips and spreads category and producer of America`s top-selling hummus. Sabra`s award-winning products offer consumers fresh new ways of eating and connecting and include a variety of flavors of hummus and a wide range of refrigerated dips and spreads including salsa, guacamole and Greek yogurt dip. Sabra Dipping Company was formed as a U.S./Canadian joint venture between Strauss Group and PepsiCo. The joint venture draws on the expertise of both Frito-Lay, a division of PepsiCo, and Strauss Group to continue building this growing business. Sabra`s core values are to be passionate, open, trusting, caring and daring.
frios helps you experience moments of happiness. reminds you to slow down and gives you a piece of elevated childhood nostalgia. we love to spread joy.
Distillers Hall is an extraordinary wedding and special events venue with stunning indoor and outdoor spaces to accommodate occasions from intimate to grand.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.